Back to KRYS

Redmile Group, LLC → KRYS

Redmile Group, LLC KRYS Position History

Krystal Biotech, Inc. • Healthcare

Quarters held
4
Latest value
$175.5M
Q3 2026
Peak value
$234.9M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$167.1M
Q1 2026$174M
Q2 2026$234.9M
Q3 2026$175.5M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$175.5M527.7K——
Q2 2026$234.9M632.0K——
Q1 2026$174M673.5K——
Q4 2025$167.1M677.7K——

Other funds holding KRYS

Other Redmile Group, LLC positions

SRRK

SCHOLAR ROCK HLDG CORP

$445.7M
SRRK

SCHOLAR ROCK HLDG CORP

$237.1M
SRRK

SCHOLAR ROCK HLDG CORP

$230M
NRIX

NURIX THERAPEUTICS INC

$187.3M
NRIX

NURIX THERAPEUTICS INC

$153.5M
SRRK

SCHOLAR ROCK HLDG CORP

$146.6M
STOK

STOKE THERAPEUTICS INC

$135.6M
STOK

STOKE THERAPEUTICS INC

$129.1M